Future Health ESG Corp. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Balance sheets

In millions of USD, except per-share amounts

	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
ASSETS
Current assets:
Cash
Prepaid expenses
Total current assets
Marketable securities held in Trust Account
Other assets
Total Assets
LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION, AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable
Accrued expenses and accounts payable
Redeemed stock payable to stockholders
Excise tax payable
Franchise and income taxes payable
Accrued expenses
Total current liabilities
Deferred underwriting and advisory fees payable
Total liabilities
Common stock subject to possible redemption; 936,447 and 1,591,537 shares issued and outstanding at redemption value of $10.75 and $10.26 per share as of December 31, 2023 and 2022, respectively
Common stock subject to possible redemption
Total common stock subject to possible redemption; 936,447 and 1,591,537 shares issued and outstanding at redemption value of $10.75 and $10.26 per share as of December 31, 2023 and 2022, respectively
Stockholders' Deficit:
Common stock, $0.0001 par value; 26,000,000 and 500,000,000 shares authorized as of December 31, 2023 and 2022, respectively; 5,000,000 shares issued and outstanding
Additional paid-in capital
Accumulated deficit
Total stockholders' deficit
Total Liabilities, Common Stock Subject to Possible Redemption, and Stockholders' Deficit

Comments